Skip to content
ClinCalc Pro
Menu
Oral tetracycline antibiotic (anti-acne)

Lymecycline 408mg (Acne)

Brand names: Tetralysal 300

Lymecycline is an oral tetracycline-class antibiotic used as a systemic treatment for moderate-to-severe inflammatory acne.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It inhibits bacterial protein synthesis by binding the 30S ribosomal subunit and also has anti-inflammatory properties, reducing Cutibacterium acnes and inflammation within the pilosebaceous unit.

Prescribing in practice

  • Contraindicated in pregnancy, breastfeeding and in children under twelve because tetracyclines cause permanent tooth discolouration and affect bone development.
  • It can cause photosensitivity, so advise sun protection and avoidance of excessive UV exposure.
  • Absorption is reduced by calcium, iron, antacids and dairy, so separate dosing from these and review concurrent use of oral retinoids.

Monitoring

Monitoring is largely clinical over a defined treatment course, reviewing acne response and tolerability and watching for rare but serious reactions such as benign intracranial hypertension.

Counselling the patient

  • Do not take if you are or might become pregnant, and use reliable contraception.
  • Protect your skin from strong sunlight as this medicine can make you burn more easily.
  • Report severe headache with visual disturbance, which needs urgent assessment.

Evidence & guidelines

Oral tetracyclines such as lymecycline are recommended by NICE as a systemic option for moderate-to-severe acne, typically combined with a topical agent.

Reference: BAD Acne Guidelines 2021; NICE CG184; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.